bluebird bio Inc (NASDAQ:BLUE)

83.12
Delayed Data
As of Jan 27
 -4.14 / -4.74%
Today’s Change
71.42
Today|||52-Week Range
163.43
-5.28%
Year-to-Date
FDA Puts GlaxoSmithKline's Blood Cancer Drug In the Fast Lane
Jan 21 / MotleyFool.com - Paid Partner Content
2 Biotech Stocks to Watch In 2020
Jan 17 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close87.26
Today’s open85.51
Day’s range83.03 - 85.87
Volume1,412,381
Average volume (3 months)1,133,280
Market cap$4.8B
Data as of 4:00pm ET, 01/27/2020

Growth & Valuation

Earnings growth (last year)-38.51%
Earnings growth (this year)-31.55%
Earnings growth (next 5 years)-64.66%
Revenue growth (last year)+54.06%
P/E ratioNM
Price/Sales94.57
Price/Book2.53

Competitors

 Today’s
change
Today’s
% change
ARWRArrowhead Pharmaceut...-0.60-1.34%
----
MORMorphoSys AG-0.64-1.95%
IMMUImmunomedics Inc-0.22-1.20%
Data as of 4:00pm ET, 01/27/2020

Financials

Next reporting dateMarch 2, 2020
EPS forecast (this quarter)-$3.77
Annual revenue (last year)$54.6M
Annual profit (last year)-$555.6M
Net profit margin-1,018.02%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts